Works matching Hematologic agents

Results: 1060
    1
    2
    3
    4
    5

    Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. 674, doi. 10.1016/j.clml.2023.05.002
    By:
    • Patel, Manish R.;
    • Donnellan, William;
    • Byrne, Michael;
    • Asch, Adam S.;
    • Zeidan, Amer M.;
    • Baer, Maria R.;
    • Fathi, Amir T.;
    • Kuykendall, Andrew T.;
    • Zheng, Fred;
    • Walker, Chris;
    • Cheng, Lulu;
    • Marando, Cindy;
    • Savona, Michael R.
    Publication type:
    Article
    6
    7
    8
    9
    10

    The phytochemical and pharmacological activity of extract Kirinyuh (Chromolaena odorata L.) leaves: A Review.

    Published in:
    Pharmacognosy Journal, 2022, v. 14, n. 5, p. 580, doi. 10.5530/pj.2022.14.139
    By:
    • Harfiani, Erna;
    • Nugraha, Yudhi;
    • Aprilia, Citra Ayu;
    • Makkiyah, Feda Anisah;
    • Puspita, Ratna;
    • Kharisma, Viol Dhea;
    • Widyananda, Muhammad Hermawan;
    • Ali Murtadlo, Ahmad Affan;
    • Rahma Turista, Dora Dayu;
    • Tamam, Muhammad Badrut;
    • Mandeli, Riso Sari;
    • Maahury, Mirella Fonda;
    • Purnamasari, Devi;
    • Ghifari, Muhammad Arya;
    • Albari, Muhammad Thoriq;
    • Ghifari, Muhammad Raffi;
    • Tasakka, Asmi Citra Malina A. R.;
    • Nugraha, Alexander Patera;
    • Zainul, Rahadian
    Publication type:
    Article
    11
    12
    13

    The new oral anticoagulants.

    Published in:
    Patient Care (Print), 2003, v. 37, n. 11, p. 13
    By:
    • Menajovsky, L. Bernardo;
    • DeEugenio, Deborah
    Publication type:
    Article
    14
    15
    16
    17
    18
    19
    20
    21

    A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 2, p. 207, doi. 10.1007/s00280-006-0259-9
    By:
    • Ma, Cynthia;
    • Mandrekar, Sumithra J.;
    • Alberts, Steven R.;
    • Croghan, Gary A.;
    • Jatoi, Aminah;
    • Reid, Joel M.;
    • Hanson, Lorelei J.;
    • Bruzek, Laura;
    • Tan, Angelina D.;
    • Pitot, Henry C.;
    • Erlichman, Charles;
    • Wright, John J.;
    • Adjei, Alex A.
    Publication type:
    Article
    22

    Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 37, doi. 10.1007/s00280-002-0443-5
    By:
    • Martell, Robert E.;
    • Peterson, Bercedis L.;
    • Cohen, Harvey Jay;
    • Petros, William P.;
    • Rai, Kanti R.;
    • Morrison, Vicki A.;
    • Elias, Laurence;
    • Shepherd, Lois;
    • Hines, John;
    • Larson, Richard A.;
    • Schiffer, Charles A.;
    • Hurwitz, Herbert I.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50